Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Clinical Oncology
|
March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
International Journal of Molecular Sciences
|
May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
Bo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
Alternatives to Laboratory Animals : ATLA
|
December 24, 2005
An inter-laboratory collaborative study by the Non-Genotoxic Carcinogen Study Group in Japan, on a cell transformation assay for tumour promoters using Bhas 42 cells
Kiyomi Ohmori, Makoto Umeda, Noriho Tanaka, et al.
Medicine International
|
July 10, 2024
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Takaki Hiwasa, Yoichi Yoshida, Masaaki Kubota, et al.
Frontiers in Cardiovascular Medicine
|
February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Scientific Reports
|
June 30, 2021
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Alternatives to Laboratory Animals : ATLA
|
April 10, 2010
Application of the improved BALB/c 3T3 cell transformation assay to the examination of the initiating and promoting activities of chemicals: the second interlaboratory collaborative study by the non-genotoxic carcinogen study group of Japan
Toshiyuki Tsuchiya, Makoto Umeda, Noriho Tanaka, et al.
Cancer Immunology, Immunotherapy : CII
|
April 16, 2022
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy
Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, et al.
BMC Medicine
|
June 9, 2021
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
Takaki Hiwasa, Hao Wang, Ken-Ichiro Goto, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
International Journal of Clinical Oncology
|
March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
International Journal of Molecular Sciences
|
May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
Bo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
Alternatives to Laboratory Animals : ATLA
|
December 24, 2005
An inter-laboratory collaborative study by the Non-Genotoxic Carcinogen Study Group in Japan, on a cell transformation assay for tumour promoters using Bhas 42 cells
Kiyomi Ohmori, Makoto Umeda, Noriho Tanaka, et al.
Medicine International
|
July 10, 2024
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Takaki Hiwasa, Yoichi Yoshida, Masaaki Kubota, et al.
Frontiers in Cardiovascular Medicine
|
February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Scientific Reports
|
June 30, 2021
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, et al.
Alternatives to Laboratory Animals : ATLA
|
April 10, 2010
Application of the improved BALB/c 3T3 cell transformation assay to the examination of the initiating and promoting activities of chemicals: the second interlaboratory collaborative study by the non-genotoxic carcinogen study group of Japan
Toshiyuki Tsuchiya, Makoto Umeda, Noriho Tanaka, et al.
Cancer Immunology, Immunotherapy : CII
|
April 16, 2022
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy
Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, et al.
BMC Medicine
|
June 9, 2021
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
Takaki Hiwasa, Hao Wang, Ken-Ichiro Goto, et al.
Page
of 8